News About: Pharm. Industry
Drug company employment relying largely on head hunters.
Many leading and even middle levels of local pharmaceutical companies have recently sought to hire outstanding employees through the head hunters, which used to be practiced by largely foreign multinational drug corpo...
Pfizer Korea to launch new love campaign for Lipitor
Pfizer Korea will launch a new love campaign for its cholesterol-lowering agent Lipitor, which will be initiated by doctors.
The love campaigns features doctor's promises to patients in a story-telling form, for in...
AZ Korea fully pushing marketing efforts for Atacand sales.
AstraZeneca Korea celebrated a launching event for Atacand as the first day of "Atacand Day" in attendance of more than 100 company staffs related with the cardiovascular drug business areas at the head office located...
Another father-son fight on March 29?
Following Dong-A Pharmaceutical's shareholders' meeting to be scheduled on March 29, some market watchers are wondering whether the firm is going into another round of the father-son dispute for control.
Dong-A Pha...
GSK to employ Korean doctors as key Asian regional position.A prestige of Korean medical doctors seems to surge up in the multinational drug corporations, appointing a key medical director in the Asia and Pacific regions.
GSK said on...
|
Hyundai to launch new Norevo emergent contraceptive.Hyundai announced that an emergent contraceptive drug called "Norevo 2T" would be soon launched with a renovated one tablet product under the new name of "Norevo One Tab".
No...
|
Abbott and Eisai to launch Humira, rheumatoid arthritis therapy.Abbott Korea and Eisai Korea jointly launched a new type of rheumatoid arthritis drug called "Humira", having mode of selectively suppressing the TNF-alfa that linked with the o...
|
Tritace Protect expanding presence in cardiovascular market
Handok Pharm said on March 16 that its Tritace Protect (ramipril) 10mg tablet has been expanding their presence in the domestic cardiovascular market since its launching on March of Last year.
Tritace Protect has b...
Korea's drug spending lowest in advanced countries
Koreans were found to have spent the least on drugs among advanced countries.
The country's drug expenditure was equivalent to 1.53 percent of its gross domestic product (GDP) in 2004, the lowest among advanced cou...
Will junior Kang be winner over senior Kang in Dong-A?
Kang Moon-seok, the son of Dong-A Pharmaceutical Chairman Kang Shin-ho, will face a bumpy road for his comeback to Korea's largest drug maker, as a prominent shareholder of the company, in the midst of its employees' ...
